Tech
Latest technology, AI, semiconductors, smartphones and tech industry news
The Bluetti Charger 2 1200W delivers 10x faster charging than standard car outlets. Learn how 75 minutes of driving can power your whole day and even jump-start your vehicle.
Get Microsoft Office 2024 Home & Business lifetime license for just $149.97 ($100 off). One-time purchase for Word, Excel, and Outlook with new AI tools.
A mysterious Polymarket bettor made $500,000 by predicting the 2026 Venezuela invasion and Nicolás Maduro's removal just days before the U.S. strike. Explore the ethics of predictive markets.
Samsung Electronics reports record Q4 2025 earnings with 20 trillion won in operating profit, driven by a 40% jump in memory chip prices during a supercycle.
Apple has officially named JPMorgan Chase as the new issuer for Apple Card, replacing Goldman Sachs. The $20B portfolio transition is expected to take two years.
Scientists have recovered a potential Leonardo da Vinci DNA sequence from Renaissance artifacts. Learn how the LDVP uses Y chromosome analysis to trace the master's genetic legacy.
Artisan AI was briefly banned from LinkedIn over data scraping and trademark concerns. Explore why this 2026 ban marks a new era of conflict between AI agents and Big Tech data policies.
With PBS shutting down and broadcast licenses under threat, Jack Dorsey's Bitchat mesh networking app emerges as a critical decentralized communication tool for emergencies.
Niko Bonatsos, the legendary investor behind Discord and Mercor, departs General Catalyst to start a new VC firm. Discover why he's betting on consumer tech and young founders in 2026.
Character.AI and Google have reached a mediated settlement with families of teens affected by chatbot interactions. Read about this pivotal 2026 AI liability case.
Replit CEO Amjad Masad reveals how Vibe Coding and specialized AI agents will replace generic 'slop' and traditional dev roadmaps by 2026.
Utah has launched a controversial AI prescription pilot program allowing AI to refill medications without human oversight. Explore the risks and benefits of this healthcare experiment.